What is CalAmp's EV / sales?

CalAmp (CAMP) reported EV / sales of 33.1× in Q1 2026.

How has CalAmp's EV / sales changed year-over-year?

CalAmp's EV / sales increased by 32.9% year-over-year, from 24.9× to 33.1×.

What does EV / sales mean?

Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.

CalAmp CAMP EV / sales

EV / sales at other companies

Ionis PharmaceuticalsIONS

12.2×+5.7×

Stoke Therapeutics, Inc.STOK

55.3×+54.8×

MeiraGTx Holdings plcMGTX

8.7×-7.2×

Taysha Gene Therapies, Inc.TSHA

144×+112×

CytomX TherapeuticsCTMX

27.9×+27.8×

Sarepta Therapeutics, Inc.SRPT

0.9×—

Other financials

Income statement

See full

Revenue$1.3M+50.8%

Operating income-$13.1M+0.2%

Net income-$18.3M-47.4%

EPS (diluted)-$0.32+48.4%

Balance sheet

See full

Cash & equivalents$100.8M+97.9%

Total debt$2.1M-73.2%

Total equity$30.9M-40.1%

Total assets$105.5M+68.0%

Cash flow

See full

Operating cash flow-$11.0M+23.1%

CapEx--100%

Free cash flow-$11.0M+24.6%

Valuation

See full

Market cap$226.92M+666%

Enterprise value$128.2M-3,860%

P/S57.7×+47.8×

Profitability

See full

Operating margin-1,335.2%-512pp

Net margin-2,193.7%-581pp

FCF margin-1,254%—

Returns & leverage

See full

Return on equity-209.3%—

Debt / equity0.1×-0.1×

Current ratio6.1×-1.9×

Where this comes from

Calculated from CalAmp’s reported figures.

enterprise value/total revenue=33.1×

Based on the most recent quarter.

The official record: CalAmp’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about CalAmp's ev / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is CalAmp's EV / sales?: CalAmp (CAMP) reported EV / sales of 33.1× in Q1 2026.
How has CalAmp's EV / sales changed year-over-year?: CalAmp's EV / sales increased by 32.9% year-over-year, from 24.9× to 33.1×.
What does EV / sales mean?: Enterprise value at the quarter end divided by trailing-twelve-month revenue. A capital-structure-neutral revenue multiple, useful when earnings are negative.